OpenAlex
PricingAboutJobs
Log inGet started
Author

Richard Jordan

Institution: University of California San Francisco Medical Center
Observed institution: University of California San Francisco Medical Center
ORCID: 0000-0002-2558-0537
Observed ORCID: 0000-0002-2558-0537
OpenAlex ID: A5124997568
Spatial transcriptomics-guided pathology biomarker as a predictor of benefit of adjuvant docetaxel in high-risk localized prostate cancer: NRG/RTOG 0521 (NCT00288080).
2026 · Md Mamunur Rahaman, Amritpal Singh, et al. · Journal of Clinical Oncology · 1
Data from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026 · Sebastian Medina, Naoto Tokuyama, et al.
Supplementary Figure S8 from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026 · Sebastian Medina, Naoto Tokuyama, et al.
Supplementary Figure S13 from A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer
2026 · Sebastian Medina, Naoto Tokuyama, et al.
Works count: 4
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms